Karachi: IBL HealthCare Limited (IBLHL) has announced its financial performance for the period ending September 30, 2024. The company disclosed a modest revenue increase alongside a dip in profit margins due to heightened operational costs and taxation.

According to information available from the Pakistan Stock Exchange (PSX), IBL HealthCare's latest financial statements indicate a slight revenue increase of 1.7%, amounting to PKR 1,079 million compared to PKR 1,061 million in the corresponding period last year. This increment reflects the company’s sustained efforts in marketing, selling, and distributing healthcare and consumer products, despite challenging market conditions.

However, the company experienced a decline in gross profit margins, dropping from 33% in the previous year to 32% in the current period. The dip is attributed to a mix of inflationary pressures and disruptions in the supply chain which have impacted cost structures across the board. Additionally, increased expenses in distribution and marketing, essential for maintaining market share, coupled with higher tax rates, have further eroded profitability.

Net profit margins consequently saw a reduction, concluding the period at 6%, down from last year’s figures. The detailed financial metrics provided include a gross profit of PKR 340 million, down from PKR 353 million last year, and a net profit after taxation of PKR 60 million, a decrease from PKR 80 million in the prior year.

Looking forward, IBL HealthCare remains committed to growth and enhancing shareholder value through improved product and service delivery. The company acknowledges the critical support of its sales force and employees, whose efforts are pivotal in navigating the current economic landscape.